Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis
- PMID: 15852401
- DOI: 10.1002/ana.20464
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis
Abstract
Dermatomyositis has been modeled as an autoimmune disease largely mediated by the adaptive immune system, including a local humorally mediated response with B and T helper cell muscle infiltration, antibody and complement-mediated injury of capillaries, and perifascicular atrophy of muscle fibers caused by ischemia. To further understand the pathophysiology of dermatomyositis, we used microarrays, computational methods, immunohistochemistry and electron microscopy to study muscle specimens from 67 patients, 54 with inflammatory myopathies, 14 with dermatomyositis. In dermatomyositis, genes induced by interferon-alpha/beta were highly overexpressed, and immunohistochemistry for the interferon-alpha/beta inducible protein MxA showed dense staining of perifascicular, and, sometimes all myofibers in 8/14 patients and on capillaries in 13/14 patients. Of 36 patients with other inflammatory myopathies, 1 patient had faint MxA staining of myofibers and 3 of capillaries. Plasmacytoid dendritic cells, potent CD4+ cellular sources of interferon-alpha, are present in substantial numbers in dermatomyositis and may account for most of the cells previously identified as T helper cells. In addition to an adaptive immune response, an innate immune response characterized by plasmacytoid dendritic cell infiltration and interferon-alpha/beta inducible gene and protein expression may be an important part of the pathogenesis of dermatomyositis, as it appears to be in systemic lupus erythematosus.
Similar articles
-
Myeloid dendritic cells in inclusion-body myositis and polymyositis.Muscle Nerve. 2007 Jan;35(1):17-23. doi: 10.1002/mus.20649. Muscle Nerve. 2007. PMID: 16969836
-
Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.Curr Opin Rheumatol. 2008 Nov;20(6):669-74. doi: 10.1097/BOR.0b013e3283157538. Curr Opin Rheumatol. 2008. PMID: 18946326 Review.
-
Inflammatory myopathies: evaluation and management.Semin Neurol. 2008 Apr;28(2):241-9. doi: 10.1055/s-2008-1062267. Semin Neurol. 2008. PMID: 18351525 Review.
-
Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.Clin Exp Dermatol. 2006 Jul;31(4):576-82. doi: 10.1111/j.1365-2230.2006.02150.x. Clin Exp Dermatol. 2006. PMID: 16716166
-
Pathogenesis of myositis in children.Curr Opin Rheumatol. 2007 Sep;19(5):487-91. doi: 10.1097/BOR.0b013e32825a6a57. Curr Opin Rheumatol. 2007. PMID: 17762616 Review.
Cited by
-
Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.World J Pediatr. 2020 Feb;16(1):31-43. doi: 10.1007/s12519-019-00313-8. Epub 2019 Sep 26. World J Pediatr. 2020. PMID: 31556011 Review.
-
Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus.Arthritis Res Ther. 2010;12 Suppl 1(Suppl 1):S6. doi: 10.1186/ar2887. Epub 2010 Apr 14. Arthritis Res Ther. 2010. PMID: 20392292 Free PMC article. Review.
-
Autoimmune Myopathies: Updates on Evaluation and Treatment.Neurotherapeutics. 2018 Oct;15(4):976-994. doi: 10.1007/s13311-018-00676-2. Neurotherapeutics. 2018. PMID: 30341597 Free PMC article. Review.
-
Clinical features of Sjögren's syndrome patients with autoantibodies against interferons.Clin Transl Med. 2019 Jan 3;8(1):1. doi: 10.1186/s40169-018-0218-1. Clin Transl Med. 2019. PMID: 30604130 Free PMC article.
-
An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity.Mol Med. 2007 Jan-Feb;13(1-2):59-68. doi: 10.2119/2006-00085.Baechler. Mol Med. 2007. PMID: 17515957 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials